Aterian (ATER) Financials

Aterian’s latest quarter shows a much smaller business than a year ago, but the company is still struggling to turn revenue into profits or positive operating cash flow. In Q1 2026, revenue was just $18,000, down sharply from $15.1 million in Q4 2025 and far below the $18.9 million reported in Q3 2025. The income statement and cash flow statement both point to an operation that is still producing meaningful losses, while the balance sheet shows a smaller but still levered company with reduced cash and a heavy reliance on short-term obligations.

There are a few positives: Aterian ended Q1 2026 with $2.3 million in cash, which is better than being near empty, and total liabilities fell to $12.7 million from $17.5 million in Q3 2025. The company also continued to reduce debt compared with earlier periods, and operating cash burn improved versus several prior quarters, helped in part by discontinued operations.

However, the bigger trend is still weak: revenue has collapsed from the 2024 levels, gross profit is now negligible, and the company remains unprofitable. Q1 2026 net loss was $6.1 million, including $3.4 million from continuing operations and $2.7 million from discontinued operations. That loss was larger than the $3.9 million loss in Q1 2025 and far worse than the $2.3 million loss in Q3 2025 from continuing operations alone.

Here are the most important takeaways for investors:

• Total liabilities declined to $12.7 million in Q1 2026 from $17.5 million in Q3 2025, showing some balance sheet cleanup.
• Cash and equivalents were $2.3 million at the end of Q1 2026, giving the company some near-term liquidity.
• Debt levels were lower than in earlier 2025 quarters, suggesting ongoing deleveraging.
• Inventory was only $52,000 in Q1 2026, which indicates a much smaller operating footprint.
• The company’s cash flow from financing remained active, meaning Aterian is still relying on debt-related moves to manage liquidity.
• Operating expenses were still very high relative to revenue, especially SG&A and marketing costs.
• Q1 2026 revenue was only $18,000, a dramatic decline from prior quarters and a major sign of business shrinkage.
• Q1 2026 operating loss was $3.2 million, showing the core business remains deeply unprofitable.
• Q1 2026 operating cash flow was negative $363,000, so the business still did not generate cash from operations.
• Retained earnings remain deeply negative at $736.8 million, reflecting years of cumulative losses.

Looking at the longer trend, Aterian has been shrinking for some time. Quarterly revenue has fallen from $39.7 million in Q3 2023 and $32.8 million in Q4 2023 to the low teens in late 2025, before collapsing to almost nothing in Q1 2026. Gross profit has also deteriorated, while marketing and SG&A expenses have remained large enough to keep operating margins negative. Even when cash flow temporarily improved in some earlier quarters, it was often driven by debt activity or working-capital swings rather than durable business strength.

The bottom line: Aterian’s financial statements do not yet show a stable turnaround. The reduced debt load and smaller liabilities are constructive, but the collapse in revenue and persistent losses are major concerns. Until the company proves it can rebuild sales and generate positive operating cash flow, the stock will likely remain speculative and high-risk.